litlas
ログインアカウント作成

Mark E. Gurney

1980–2025 年に発表

83
論文数
22,892
被引用数
63
h 指数
79
i10 指数

被引用数

Mark E. Gurney の年別被引用数1951 年: 被引用 1 件1980 年: 被引用 1 件1981 年: 被引用 7 件1982 年: 被引用 4 件1983 年: 被引用 7 件1984 年: 被引用 14 件1985 年: 被引用 18 件1986 年: 被引用 15 件1987 年: 被引用 29 件1988 年: 被引用 71 件1989 年: 被引用 46 件1990 年: 被引用 39 件1991 年: 被引用 36 件1992 年: 被引用 20 件1993 年: 被引用 18 件1994 年: 被引用 19 件1995 年: 被引用 46 件1996 年: 被引用 83 件1997 年: 被引用 121 件1998 年: 被引用 139 件1999 年: 被引用 176 件2000 年: 被引用 210 件2001 年: 被引用 243 件2002 年: 被引用 300 件2003 年: 被引用 386 件2004 年: 被引用 395 件2005 年: 被引用 336 件2006 年: 被引用 350 件2007 年: 被引用 341 件2008 年: 被引用 371 件2009 年: 被引用 330 件2010 年: 被引用 276 件2011 年: 被引用 307 件2012 年: 被引用 250 件2013 年: 被引用 204 件2014 年: 被引用 193 件2015 年: 被引用 156 件2016 年: 被引用 133 件2017 年: 被引用 130 件2018 年: 被引用 94 件2019 年: 被引用 339 件2020 年: 被引用 325 件2021 年: 被引用 379 件2022 年: 被引用 350 件2023 年: 被引用 209 件2024 年: 被引用 314 件2025 年: 被引用 181 件2026 年: 被引用 6 件1952〜1979 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,095 件、この内訳の 34.6%イギリス: 引用元論文 671 件、この内訳の 7.5%ドイツ: 引用元論文 509 件、この内訳の 5.7%中国: 引用元論文 504 件、この内訳の 5.6%イタリア: 引用元論文 420 件、この内訳の 4.7%カナダ: 引用元論文 364 件、この内訳の 4.1%日本: 引用元論文 360 件、この内訳の 4%フランス: 引用元論文 276 件、この内訳の 3.1%オーストラリア: 引用元論文 243 件、この内訳の 2.7%スウェーデン: 引用元論文 232 件、この内訳の 2.6%オランダ: 引用元論文 202 件、この内訳の 2.3%スペイン: 引用元論文 167 件、この内訳の 1.9%
0%34.6%その他 21.2%

機関

分野

  • Medicine54.7%
  • Biochemistry, Genetics and Molecular Biology27.9%
  • Neuroscience8.7%
  • Immunology and Microbiology3.8%
  • Computer Science1.3%
  • Nursing1.3%
  • その他2.3%

トピック

  • Amyotrophic Lateral Sclerosis Research9.3%
  • Alzheimer's disease research and treatments6.7%
  • Neurogenetic and Muscular Disorders Research5%
  • Cholinesterase and Neurodegenerative Diseases3.6%
  • Parkinson's Disease Mechanisms and Treatments2.9%
  • Computational Drug Discovery Methods2.2%
  • その他70.3%

共著者

全論文

検索で開く
  1. Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation

    著者: Mark E. Gurney, Haifeng Pu, Arlene Y. Chiu, Mauro C. Dal Canto, Cynthia Y. Polchow, Denise D. Alexander, Jan Caliendo, Afif Hentati, Young W. Kwon, Han‐Xiang Deng, Wenje Chen, Ping Zhai, Robert Sufit, Teepu Siddique - Science 1994 被引用: 4,158

  2. Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US

    著者: William Yang Wang, QuangQiu Wang, Xin Qi, Mark E. Gurney, George Perry, Nora D. Volkow, Pamela B. Davis, David C. Kaelber, Rong Xu - Alzheimer s & Dementia 2024 被引用: 141

  3. Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial

    著者: Elizabeth Berry‐Kravis, Mark Harnett, Scott A. Reines, Melody Reese, Lauren E. Ethridge, Abigail H. Outterson, Claire Michalak, Jeremiah Furman, Mark E. Gurney - Nature Medicine 2021 被引用: 131

  4. CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide

    著者: Mark E. Gurney, Arwen Stikvoort, Emma Nolan, Lucy Kirkham-McCarthy, Stanislav Khoruzhenko, Rama Shivakumar, Sonja Zweegman, Niels W.C.J. van de Donk, Tuna Mutis, Éva Szegezdi, Subhashis Sarkar, Michael O’Dwyer - Haematologica 2020 被引用: 110

  5. Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis

    著者: Mengshi Zhou, Rong Xu, David C. Kaelber, Mark E. Gurney - PLoS ONE 2020 被引用: 153

  6. COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US

    著者: QuanQiu Wang, Pamela B. Davis, Mark E. Gurney, Rong Xu - Alzheimer s & Dementia 2021 被引用: 273

  7. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes

    著者: Valgerður Steinthórsdóttir, Guðmar Þorleifsson, Inga Reynisdóttir, Rafn Benediktsson, Þorbjörg Jónsdóttir, G. Bragi Walters, Unnur Styrkársdóttir, Sólveig Grétarsdóttir, Valur Emilsson, Shyamali Ghosh, Adam Baker, Steinunn Snorradóttir, Hjördis Bjarnason, Maggie Ng, Torben Hansen, Yu Z. Bagger, Robert L. Wilensky, Muredach P. Reilly, Adebowale Adeyemo, Yuanxiu Chen, Jie Zhou, Vilmundur Guðnason, Guanjie Chen, Hanxia Huang, Kerrie Lashley, Ayo P. Doumatey, Wing‐Yee So, Ronald C.W., Gitte Andersen, Knut Borch‐Johnsen, Torben Jørgensen, Jana V. van Vliet‐Ostaptchouk, Marten H. Hofker, Cisca Wijmenga, Claus Christiansen, Daniel J. Rader, Charles N. Rotimi, Mark E. Gurney, Juliana C.N. Chan, Oluf Pedersen, Gunnar Sigurðsson, Jeffrey R. Gulcher, Unnur Þorsteinsdóttir, Augustine Kong, Kāri Stefánsson - Nature Genetics 2007 被引用: 1,085

  8. Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor–natural killer cells

    著者: Mark E. Gurney, Eimear O’Reilly, Sarah Corcoran, Sarah Brophy, Janusz Krawczyk, Neil Otto, David Hermanson, Richard Childs, Éva Szegezdi, Michael O’Dwyer - Cytotherapy 2022 被引用: 38

  9. Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety

    著者: Alex B. Burgin, Ólafur Þ. Magnússon, Jasbir Singh, Pam Witte, Bart L. Staker, Jón Már Björnsson, Margrét Þorsteinsdóttir, Sigrún Hrafnsdóttir, Timothy J. Hagen, Alex S. Kiselyov, Lance Stewart, Mark E. Gurney - Nature Biotechnology 2009 被引用: 394

  10. Features and Factors Associated With Myeloid Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

    著者: Mark E. Gurney, Anmol Baranwal, Allison Rosenthal, Mohamed A. Kharfan‐Dabaja, Saad S. Kenderian, Yi Lin, Mithun Vinod Shah - JAMA Oncology 2024 被引用: 24

  11. Feeder Cells at the Interface of Natural Killer Cell Activation, Expansion and Gene Editing

    著者: Mark E. Gurney, Soumyadipta Kundu, Shubham Pandey, Michael O’Dwyer - Frontiers in Immunology 2022 被引用: 47

  12. Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity

    著者: Riqiang Yan, Michael J. Bienkowski, Mary E. Shuck, Huiyi Miao, Monica C. Tory, Adele M. Pauley, John R. Brashler, Nancy C. Stratman, W. Rodney Mathews, Allen E. Buhl, Donald B. Carter, Alfredo G. Tomasselli, L. Parodi, Robert L. Heinrikson, Mark E. Gurney - Nature 1999 被引用: 1,434

  13. Phosphodiesterase-4 (PDE4) Molecular Pharmacology and Alzheimer's Disease

    著者: Mark E. Gurney, Emily C. D’Amato, Alex B. Burgin - Neurotherapeutics 2014 被引用: 118

  14. Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders

    著者: Mark E. Gurney, Richard A. Nugent, Xuesheng Mo, Janice A. Sindac, Timothy J. Hagen, David Fox, James M. O’Donnell, Chong Zhang, Ying Xu, Han‐Ting Zhang, Vincent E. Groppi, Marc B. Bailie, Ronald E. White, Donna L. Romero, A. Samuel Vellekoop, Joel R. Walker, Matthew D. Surman, Lei Zhu, Robert F. Campbell - Journal of Medicinal Chemistry 2019 被引用: 74

  15. Realizing Innate Potential: CAR-NK Cell Therapies for Acute Myeloid Leukemia

    著者: Mark E. Gurney, Michael O’Dwyer - Cancers 2021 被引用: 37

  16. Gut–microbiota–microglia–brain interactions in Alzheimer’s disease: knowledge-based, multi-dimensional characterization

    著者: QuanQiu Wang, Pamela B. Davis, Xin Qi, Shu G. Chen, Mark E. Gurney, George Perry, P. Murali Doraiswamy, Rong Xu - Alzheimer s Research & Therapy 2021 被引用: 32

  17. aph-1 and pen-2 Are Required for Notch Pathway Signaling, γ-Secretase Cleavage of βAPP, and Presenilin Protein Accumulation

    著者: Ross S. Francis, Garth McGrath, Jianhua Zhang, David A. Ruddy, Mary Sym, Javier Apfeld, Monique Nicoll, Mark Maxwell, Bing Hai, Michael C. Ellis, Annette L. Parks, Wei Xu, Jinhe Li, Mark E. Gurney, Richard L. Myers, Carol S. Himes, Ronald R. Hiebsch, Cara Ruble, Jeffrey S. Nye, Daniel Curtis - Developmental Cell 2002 被引用: 796

  18. Potential long‐term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans

    著者: Chunlei Zheng, Nathanael R. Fillmore, Jaime Ramos‐Cejudo, Mary T. Brophy, Ricardo S. Osorio, Mark E. Gurney, Wei Qiao Qiu, Rhoda Au, George Perry, Maureen Dubreuil, Shu G. Chen, Xin Qi, Pamela B. Davis, Nhan Do, Rong Xu - Alzheimer s & Dementia 2021 被引用: 26

  19. PDE4 subtypes in cancer

    著者: Samuel H. Lai, Guston Zervoudakis, Jesse Chou, Mark E. Gurney, Kelly M. Quesnelle - Oncogene 2020 被引用: 99

  20. Generating natural killer cells for adoptive transfer: expanding horizons

    著者: Soumyadipta Kundu, Mark E. Gurney, Michael O’Dwyer - Cytotherapy 2021 被引用: 76

  21. Neuregulin 1 and Susceptibility to Schizophrenia

    著者: Hreinn Stefánsson, Hannes Pétursson, Engilbert Sigurðsson, Valgerður Steinthórsdóttir, Soley Bjornsdottir, Thordur Sigmundsson, Shyamali Ghosh, Jon Brynjolfsson, Steinunn Gunnarsdottir, Omar Ivarsson, Thomas T. Chou, Ómar Hjaltason, Birgitta Birgisdottir, Helgi Jónsson, Vala G Gudnadottir, Elsa Gudmundsdottir, Ásgeir Björnsson, Brynjolfur Ingvarsson, Andrés Ingason, Sigmundur Sigfússon, Hrönn Harðardóttir, Richard P. Harvey, Donna Lai, Mingdong Zhou, Daniela Brunner, Vincent Mutel, Acuna Gonzalo, Greg Lemke, Jesús Sainz, G Jóhannesson, Þorkell Andrésson, Daníel F. Guðbjartsson, Andrei Manolescu, Michael L. Frigge, Mark E. Gurney, Augustine Kong, Jeffrey R. Gulcher, Kāri Stefánsson - The American Journal of Human Genetics 2002 被引用: 1,689

  22. Formation of high molecular weight complexes of mutant Cu,Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis

    著者: Jennifer Johnston, Muffie J. Dalton, Mark E. Gurney, Ron R. Kopito - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 被引用: 599

  23. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.

    著者: Pang‐Hsien Tu, P Raju, Kent A. Robinson, Mark E. Gurney, John Q. Trojanowski, V M Lee - National Academy of Sciences, Proceedings of the National Academy of Sciences 1996 被引用: 412

  24. Structural basis for the design of selective phosphodiesterase 4B inhibitors

    著者: David Fox, Alex B. Burgin, Mark E. Gurney - Cellular Signalling 2013 被引用: 104